Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation for Inmunology (INMB), a clinical-stage immunology company developing two biologic therapeutic platforms targeting innate immune dysfunction. The company's pipeline includes candidates for Alzheimer's disease, prostate cancer, and other neurological conditions and cancers, with clinical data expected in 2024-2025.
investor_presentation
12 Pages
Volkswagen